MTOR and hepatocellular carcinoma: Its affinity towards Mac-2-binding protein (being produced by stromal cells of cirrhotic liver and correlating with hepatocellular carcinoma (HCC) via galectin-3/mTOR pathway enhancement) due to increased branching and decreased sialylation has been shown to be a promising biomarker of HCC [132,133,134].